This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program – Diabetes Technology & Therapeutics – 2018
This website is supported by an educational grant from DexCom, Inc.
Province (Required) ---AlbertaBritish ColumbiaManitobaNew BrunswickNewfoundland and LabradorNorthwest TerritoriesNova ScotiaNunavutOntarioPrince Edward IslandQuebecSaskatchewanYukonNot Applicable
How did you hear about Canada CGM (Required) ---Search EngineWord of MouthSocial MediaPrintOther
I would like to receive email updates about continuous glucose monitoring insights and education from Impact Education, LLC